世界のイバンドロン酸ナトリウム注射市場インサイト・予測（～2027年）

• 英文タイトル：Global Ibandronate Sodium Injection Market Insights and Forecast to 2027

• レポートコード：QY2108PAL4071 • 出版社/出版日：QYResearch / 2021年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査資料はイバンドロン酸ナトリウム注射の世界市場の現状について調査・分析し、2027年までの市場を予測しました。イバンドロン酸ナトリウム注射の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（4ml：2mg、2ml：2mg、1：1mg）、用途別市場規模（高カルシウム血症、骨粗鬆症）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・イバンドロン酸ナトリウム注射の世界市場概要 ・メーカー別の競争状況、市場シェア ・イバンドロン酸ナトリウム注射の種類別市場規模：4ml：2mg、2ml：2mg、1：1mg ・イバンドロン酸ナトリウム注射の用途別市場規模：高カルシウム血症、骨粗鬆症 ・北米のイバンドロン酸ナトリウム注射市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパのイバンドロン酸ナトリウム注射市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアのイバンドロン酸ナトリウム注射市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米のイバンドロン酸ナトリウム注射市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカのイバンドロン酸ナトリウム注射市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Qilu Pharmaceutical Co., Ltd、Hebei Renhe Yikang Pharmaceutical Co. Ltd、Chengdu Yuandong Biopharmaceutical Co. Ltd、Sichuan Meida Kang Jia Le Pharmaceutical Co. Ltd、Biomedical Engineering Center, Hebei Medical University、Roche、Genentech ・イバンドロン酸ナトリウム注射のバリューチェーン・販売チャネル分析 ・イバンドロン酸ナトリウム注射の世界市場動向

Ibandronate Sodium Injection for the treatment of postmenopausal osteoporosis; For the treatment of bone pain caused by osteolytic bone metastases of malignant tumors

Market Analysis and Insights: Global Ibandronate Sodium Injection Market
The global Ibandronate Sodium Injection market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Ibandronate Sodium Injection Scope and Segment
Ibandronate Sodium Injection market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ibandronate Sodium Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
4ml:2mg
2ml:2mg
1:1mg

Segment by Application
Hypercalcemia
Osteoporosis

By Company
Qilu Pharmaceutical Co., Ltd
Hebei Renhe Yikang Pharmaceutical Co. Ltd
Chengdu Yuandong Biopharmaceutical Co. Ltd
Sichuan Meida Kang Jia Le Pharmaceutical Co. Ltd
Biomedical Engineering Center, Hebei Medical University
Roche
Genentech

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Ibandronate Sodium Injection Product Introduction
1.2 Market by Type
1.2.1 Global Ibandronate Sodium Injection Market Size Growth Rate by Type
1.2.2 4ml:2mg
1.2.3 2ml:2mg
1.2.4 1:1mg
1.3 Market by Application
1.3.1 Global Ibandronate Sodium Injection Market Size Growth Rate by Application
1.3.2 Hypercalcemia
1.3.3 Osteoporosis
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Ibandronate Sodium Injection Sales Estimates and Forecasts 2016-2027
2.2 Global Ibandronate Sodium Injection Revenue Estimates and Forecasts 2016-2027
2.3 Global Ibandronate Sodium Injection Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Ibandronate Sodium Injection Regions by Sales
2.4.1 Global Top Ibandronate Sodium Injection Regions by Sales (2016-2021)
2.4.2 Global Top Ibandronate Sodium Injection Regions by Sales (2022-2027)
2.5 Global Top Ibandronate Sodium Injection Regions by Revenue
2.5.1 Global Top Ibandronate Sodium Injection Regions by Revenue (2016-2021)
2.5.2 Global Top Ibandronate Sodium Injection Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Ibandronate Sodium Injection Sales by Manufacturers
3.1.1 Global Top Ibandronate Sodium Injection Manufacturers by Sales (2016-2021)
3.1.2 Global Top Ibandronate Sodium Injection Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Ibandronate Sodium Injection Sales in 2020
3.2 Global Ibandronate Sodium Injection Revenue by Manufacturers
3.2.1 Global Top Ibandronate Sodium Injection Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Ibandronate Sodium Injection Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Ibandronate Sodium Injection Revenue in 2020
3.3 Global Ibandronate Sodium Injection Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Ibandronate Sodium Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Ibandronate Sodium Injection Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Ibandronate Sodium Injection Sales by Type
4.1.1 Global Ibandronate Sodium Injection Historical Sales by Type (2016-2021)
4.1.2 Global Ibandronate Sodium Injection Forecasted Sales by Type (2022-2027)
4.1.3 Global Ibandronate Sodium Injection Sales Market Share by Type (2016-2027)
4.2 Global Ibandronate Sodium Injection Revenue by Type
4.2.1 Global Ibandronate Sodium Injection Historical Revenue by Type (2016-2021)
4.2.2 Global Ibandronate Sodium Injection Forecasted Revenue by Type (2022-2027)
4.2.3 Global Ibandronate Sodium Injection Revenue Market Share by Type (2016-2027)
4.3 Global Ibandronate Sodium Injection Price by Type
4.3.1 Global Ibandronate Sodium Injection Price by Type (2016-2021)
4.3.2 Global Ibandronate Sodium Injection Price Forecast by Type (2022-2027)

5 Market Size by Application
5.1 Global Ibandronate Sodium Injection Sales by Application
5.1.1 Global Ibandronate Sodium Injection Historical Sales by Application (2016-2021)
5.1.2 Global Ibandronate Sodium Injection Forecasted Sales by Application (2022-2027)
5.1.3 Global Ibandronate Sodium Injection Sales Market Share by Application (2016-2027)
5.2 Global Ibandronate Sodium Injection Revenue by Application
5.2.1 Global Ibandronate Sodium Injection Historical Revenue by Application (2016-2021)
5.2.2 Global Ibandronate Sodium Injection Forecasted Revenue by Application (2022-2027)
5.2.3 Global Ibandronate Sodium Injection Revenue Market Share by Application (2016-2027)
5.3 Global Ibandronate Sodium Injection Price by Application
5.3.1 Global Ibandronate Sodium Injection Price by Application (2016-2021)
5.3.2 Global Ibandronate Sodium Injection Price Forecast by Application (2022-2027)

6 North America
6.1 North America Ibandronate Sodium Injection Market Size by Type
6.1.1 North America Ibandronate Sodium Injection Sales by Type (2016-2027)
6.1.2 North America Ibandronate Sodium Injection Revenue by Type (2016-2027)
6.2 North America Ibandronate Sodium Injection Market Size by Application
6.2.1 North America Ibandronate Sodium Injection Sales by Application (2016-2027)
6.2.2 North America Ibandronate Sodium Injection Revenue by Application (2016-2027)
6.3 North America Ibandronate Sodium Injection Market Size by Country
6.3.1 North America Ibandronate Sodium Injection Sales by Country (2016-2027)
6.3.2 North America Ibandronate Sodium Injection Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada

7 Europe
7.1 Europe Ibandronate Sodium Injection Market Size by Type
7.1.1 Europe Ibandronate Sodium Injection Sales by Type (2016-2027)
7.1.2 Europe Ibandronate Sodium Injection Revenue by Type (2016-2027)
7.2 Europe Ibandronate Sodium Injection Market Size by Application
7.2.1 Europe Ibandronate Sodium Injection Sales by Application (2016-2027)
7.2.2 Europe Ibandronate Sodium Injection Revenue by Application (2016-2027)
7.3 Europe Ibandronate Sodium Injection Market Size by Country
7.3.1 Europe Ibandronate Sodium Injection Sales by Country (2016-2027)
7.3.2 Europe Ibandronate Sodium Injection Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Ibandronate Sodium Injection Market Size by Type
8.1.1 Asia Pacific Ibandronate Sodium Injection Sales by Type (2016-2027)
8.1.2 Asia Pacific Ibandronate Sodium Injection Revenue by Type (2016-2027)
8.2 Asia Pacific Ibandronate Sodium Injection Market Size by Application
8.2.1 Asia Pacific Ibandronate Sodium Injection Sales by Application (2016-2027)
8.2.2 Asia Pacific Ibandronate Sodium Injection Revenue by Application (2016-2027)
8.3 Asia Pacific Ibandronate Sodium Injection Market Size by Region
8.3.1 Asia Pacific Ibandronate Sodium Injection Sales by Region (2016-2027)
8.3.2 Asia Pacific Ibandronate Sodium Injection Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia

9 Latin America
9.1 Latin America Ibandronate Sodium Injection Market Size by Type
9.1.1 Latin America Ibandronate Sodium Injection Sales by Type (2016-2027)
9.1.2 Latin America Ibandronate Sodium Injection Revenue by Type (2016-2027)
9.2 Latin America Ibandronate Sodium Injection Market Size by Application
9.2.1 Latin America Ibandronate Sodium Injection Sales by Application (2016-2027)
9.2.2 Latin America Ibandronate Sodium Injection Revenue by Application (2016-2027)
9.3 Latin America Ibandronate Sodium Injection Market Size by Country
9.3.1 Latin America Ibandronate Sodium Injection Sales by Country (2016-2027)
9.3.2 Latin America Ibandronate Sodium Injection Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia

10 Middle East and Africa
10.1 Middle East and Africa Ibandronate Sodium Injection Market Size by Type
10.1.1 Middle East and Africa Ibandronate Sodium Injection Sales by Type (2016-2027)
10.1.2 Middle East and Africa Ibandronate Sodium Injection Revenue by Type (2016-2027)
10.2 Middle East and Africa Ibandronate Sodium Injection Market Size by Application
10.2.1 Middle East and Africa Ibandronate Sodium Injection Sales by Application (2016-2027)
10.2.2 Middle East and Africa Ibandronate Sodium Injection Revenue by Application (2016-2027)
10.3 Middle East and Africa Ibandronate Sodium Injection Market Size by Country
10.3.1 Middle East and Africa Ibandronate Sodium Injection Sales by Country (2016-2027)
10.3.2 Middle East and Africa Ibandronate Sodium Injection Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 Qilu Pharmaceutical Co., Ltd
11.1.1 Qilu Pharmaceutical Co., Ltd Corporation Information
11.1.2 Qilu Pharmaceutical Co., Ltd Overview
11.1.3 Qilu Pharmaceutical Co., Ltd Ibandronate Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Qilu Pharmaceutical Co., Ltd Ibandronate Sodium Injection Product Description
11.1.5 Qilu Pharmaceutical Co., Ltd Recent Developments
11.2 Hebei Renhe Yikang Pharmaceutical Co. Ltd
11.2.1 Hebei Renhe Yikang Pharmaceutical Co. Ltd Corporation Information
11.2.2 Hebei Renhe Yikang Pharmaceutical Co. Ltd Overview
11.2.3 Hebei Renhe Yikang Pharmaceutical Co. Ltd Ibandronate Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Hebei Renhe Yikang Pharmaceutical Co. Ltd Ibandronate Sodium Injection Product Description
11.2.5 Hebei Renhe Yikang Pharmaceutical Co. Ltd Recent Developments
11.3 Chengdu Yuandong Biopharmaceutical Co. Ltd
11.3.1 Chengdu Yuandong Biopharmaceutical Co. Ltd Corporation Information
11.3.2 Chengdu Yuandong Biopharmaceutical Co. Ltd Overview
11.3.3 Chengdu Yuandong Biopharmaceutical Co. Ltd Ibandronate Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Chengdu Yuandong Biopharmaceutical Co. Ltd Ibandronate Sodium Injection Product Description
11.3.5 Chengdu Yuandong Biopharmaceutical Co. Ltd Recent Developments
11.4 Sichuan Meida Kang Jia Le Pharmaceutical Co. Ltd
11.4.1 Sichuan Meida Kang Jia Le Pharmaceutical Co. Ltd Corporation Information
11.4.2 Sichuan Meida Kang Jia Le Pharmaceutical Co. Ltd Overview
11.4.3 Sichuan Meida Kang Jia Le Pharmaceutical Co. Ltd Ibandronate Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Sichuan Meida Kang Jia Le Pharmaceutical Co. Ltd Ibandronate Sodium Injection Product Description
11.4.5 Sichuan Meida Kang Jia Le Pharmaceutical Co. Ltd Recent Developments
11.5 Biomedical Engineering Center, Hebei Medical University
11.5.1 Biomedical Engineering Center, Hebei Medical University Corporation Information
11.5.2 Biomedical Engineering Center, Hebei Medical University Overview
11.5.3 Biomedical Engineering Center, Hebei Medical University Ibandronate Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Biomedical Engineering Center, Hebei Medical University Ibandronate Sodium Injection Product Description
11.5.5 Biomedical Engineering Center, Hebei Medical University Recent Developments
11.6 Roche
11.6.1 Roche Corporation Information
11.6.2 Roche Overview
11.6.3 Roche Ibandronate Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Roche Ibandronate Sodium Injection Product Description
11.6.5 Roche Recent Developments
11.7 Genentech
11.7.1 Genentech Corporation Information
11.7.2 Genentech Overview
11.7.3 Genentech Ibandronate Sodium Injection Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Genentech Ibandronate Sodium Injection Product Description
11.7.5 Genentech Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Ibandronate Sodium Injection Value Chain Analysis
12.2 Ibandronate Sodium Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Ibandronate Sodium Injection Production Mode & Process
12.4 Ibandronate Sodium Injection Sales and Marketing
12.4.1 Ibandronate Sodium Injection Sales Channels
12.4.2 Ibandronate Sodium Injection Distributors
12.5 Ibandronate Sodium Injection Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Ibandronate Sodium Injection Industry Trends
13.2 Ibandronate Sodium Injection Market Drivers
13.3 Ibandronate Sodium Injection Market Challenges
13.4 Ibandronate Sodium Injection Market Restraints

14 Key Findings in The Global Ibandronate Sodium Injection Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Ibandronate Sodium Injection Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of 4ml:2mg
Table 3. Major Manufacturers of 2ml:2mg
Table 4. Major Manufacturers of 1:1mg
Table 5. Global Ibandronate Sodium Injection Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Ibandronate Sodium Injection Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Ibandronate Sodium Injection Sales by Region (2016-2021) & (K Doses)
Table 8. Global Ibandronate Sodium Injection Sales Market Share by Region (2016-2021)
Table 9. Global Ibandronate Sodium Injection Sales by Region (2022-2027) & (K Doses)
Table 10. Global Ibandronate Sodium Injection Sales Market Share by Region (2022-2027)
Table 11. Global Ibandronate Sodium Injection Revenue by Region (2016-2021) & (US$ Million)
Table 12. Global Ibandronate Sodium Injection Revenue Market Share by Region (2016-2021)
Table 13. Global Ibandronate Sodium Injection Revenue by Region (2022-2027) & (US$ Million)
Table 14. Global Ibandronate Sodium Injection Revenue Market Share by Region (2022-2027)
Table 15. Global Ibandronate Sodium Injection Sales by Manufacturers (2016-2021) & (K Doses)
Table 16. Global Ibandronate Sodium Injection Sales Share by Manufacturers (2016-2021)
Table 17. Global Ibandronate Sodium Injection Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 18. Global Ibandronate Sodium Injection Revenue Share by Manufacturers (2016-2021)
Table 19. Ibandronate Sodium Injection Price by Manufacturers 2016-2021 (US$/Dose)
Table 20. Global Ibandronate Sodium Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Ibandronate Sodium Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ibandronate Sodium Injection as of 2020)
Table 22. Ibandronate Sodium Injection Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Ibandronate Sodium Injection Product Offered
Table 24. Date of Manufacturers Enter into Ibandronate Sodium Injection Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Ibandronate Sodium Injection Sales by Type (2016-2021) & (K Doses)
Table 27. Global Ibandronate Sodium Injection Sales by Type (2022-2027) & (K Doses)
Table 28. Global Ibandronate Sodium Injection Sales Share by Type (2016-2021)
Table 29. Global Ibandronate Sodium Injection Sales Share by Type (2022-2027)
Table 30. Global Ibandronate Sodium Injection Revenue by Type (2016-2021) & (US$ Million)
Table 31. Global Ibandronate Sodium Injection Revenue by Type (2022-2027) & (US$ Million)
Table 32. Global Ibandronate Sodium Injection Revenue Share by Type (2016-2021)
Table 33. Global Ibandronate Sodium Injection Revenue Share by Type (2022-2027)
Table 34. Ibandronate Sodium Injection Price by Type (2016-2021) & (US$/Dose)
Table 35. Global Ibandronate Sodium Injection Price Forecast by Type (2022-2027) & (US$/Dose)
Table 36. Global Ibandronate Sodium Injection Sales by Application (2016-2021) & (K Doses)
Table 37. Global Ibandronate Sodium Injection Sales by Application (2022-2027) & (K Doses)
Table 38. Global Ibandronate Sodium Injection Sales Share by Application (2016-2021)
Table 39. Global Ibandronate Sodium Injection Sales Share by Application (2022-2027)
Table 40. Global Ibandronate Sodium Injection Revenue by Application (2016-2021) & (US$ Million)
Table 41. Global Ibandronate Sodium Injection Revenue by Application (2022-2027) & (US$ Million)
Table 42. Global Ibandronate Sodium Injection Revenue Share by Application (2016-2021)
Table 43. Global Ibandronate Sodium Injection Revenue Share by Application (2022-2027)
Table 44. Ibandronate Sodium Injection Price by Application (2016-2021) & (US$/Dose)
Table 45. Global Ibandronate Sodium Injection Price Forecast by Application (2022-2027) & (US$/Dose)
Table 46. North America Ibandronate Sodium Injection Sales by Type (2016-2021) & (K Doses)
Table 47. North America Ibandronate Sodium Injection Sales by Type (2022-2027) & (K Doses)
Table 48. North America Ibandronate Sodium Injection Revenue by Type (2016-2021) & (US$ Million)
Table 49. North America Ibandronate Sodium Injection Revenue by Type (2022-2027) & (US$ Million)
Table 50. North America Ibandronate Sodium Injection Sales by Application (2016-2021) & (K Doses)
Table 51. North America Ibandronate Sodium Injection Sales by Application (2022-2027) & (K Doses)
Table 52. North America Ibandronate Sodium Injection Revenue by Application (2016-2021) & (US$ Million)
Table 53. North America Ibandronate Sodium Injection Revenue by Application (2022-2027) & (US$ Million)
Table 54. North America Ibandronate Sodium Injection Sales by Country (2016-2021) & (K Doses)
Table 55. North America Ibandronate Sodium Injection Sales by Country (2022-2027) & (K Doses)
Table 56. North America Ibandronate Sodium Injection Revenue by Country (2016-2021) & (US$ Million)
Table 57. North America Ibandronate Sodium Injection Revenue by Country (2022-2027) & (US$ Million)
Table 58. Europe Ibandronate Sodium Injection Sales by Type (2016-2021) & (K Doses)
Table 59. Europe Ibandronate Sodium Injection Sales by Type (2022-2027) & (K Doses)
Table 60. Europe Ibandronate Sodium Injection Revenue by Type (2016-2021) & (US$ Million)
Table 61. Europe Ibandronate Sodium Injection Revenue by Type (2022-2027) & (US$ Million)
Table 62. Europe Ibandronate Sodium Injection Sales by Application (2016-2021) & (K Doses)
Table 63. Europe Ibandronate Sodium Injection Sales by Application (2022-2027) & (K Doses)
Table 64. Europe Ibandronate Sodium Injection Revenue by Application (2016-2021) & (US$ Million)
Table 65. Europe Ibandronate Sodium Injection Revenue by Application (2022-2027) & (US$ Million)
Table 66. Europe Ibandronate Sodium Injection Sales by Country (2016-2021) & (K Doses)
Table 67. Europe Ibandronate Sodium Injection Sales by Country (2022-2027) & (K Doses)
Table 68. Europe Ibandronate Sodium Injection Revenue by Country (2016-2021) & (US$ Million)
Table 69. Europe Ibandronate Sodium Injection Revenue by Country (2022-2027) & (US$ Million)
Table 70. Asia Pacific Ibandronate Sodium Injection Sales by Type (2016-2021) & (K Doses)
Table 71. Asia Pacific Ibandronate Sodium Injection Sales by Type (2022-2027) & (K Doses)
Table 72. Asia Pacific Ibandronate Sodium Injection Revenue by Type (2016-2021) & (US$ Million)
Table 73. Asia Pacific Ibandronate Sodium Injection Revenue by Type (2022-2027) & (US$ Million)
Table 74. Asia Pacific Ibandronate Sodium Injection Sales by Application (2016-2021) & (K Doses)
Table 75. Asia Pacific Ibandronate Sodium Injection Sales by Application (2022-2027) & (K Doses)
Table 76. Asia Pacific Ibandronate Sodium Injection Revenue by Application (2016-2021) & (US$ Million)
Table 77. Asia Pacific Ibandronate Sodium Injection Revenue by Application (2022-2027) & (US$ Million)
Table 78. Asia Pacific Ibandronate Sodium Injection Sales by Region (2016-2021) & (K Doses)
Table 79. Asia Pacific Ibandronate Sodium Injection Sales by Region (2022-2027) & (K Doses)
Table 80. Asia Pacific Ibandronate Sodium Injection Revenue by Region (2016-2021) & (US$ Million)
Table 81. Asia Pacific Ibandronate Sodium Injection Revenue by Region (2022-2027) & (US$ Million)
Table 82. Latin America Ibandronate Sodium Injection Sales by Type (2016-2021) & (K Doses)
Table 83. Latin America Ibandronate Sodium Injection Sales by Type (2022-2027) & (K Doses)
Table 84. Latin America Ibandronate Sodium Injection Revenue by Type (2016-2021) & (US$ Million)
Table 85. Latin America Ibandronate Sodium Injection Revenue by Type (2022-2027) & (US$ Million)
Table 86. Latin America Ibandronate Sodium Injection Sales by Application (2016-2021) & (K Doses)
Table 87. Latin America Ibandronate Sodium Injection Sales by Application (2022-2027) & (K Doses)
Table 88. Latin America Ibandronate Sodium Injection Revenue by Application (2016-2021) & (US$ Million)
Table 89. Latin America Ibandronate Sodium Injection Revenue by Application (2022-2027) & (US$ Million)
Table 90. Latin America Ibandronate Sodium Injection Sales by Country (2016-2021) & (K Doses)
Table 91. Latin America Ibandronate Sodium Injection Sales by Country (2022-2027) & (K Doses)
Table 92. Latin America Ibandronate Sodium Injection Revenue by Country (2016-2021) & (US$ Million)
Table 93. Latin America Ibandronate Sodium Injection Revenue by Country (2022-2027) & (US$ Million)
Table 94. Middle East and Africa Ibandronate Sodium Injection Sales by Type (2016-2021) & (K Doses)
Table 95. Middle East and Africa Ibandronate Sodium Injection Sales by Type (2022-2027) & (K Doses)
Table 96. Middle East and Africa Ibandronate Sodium Injection Revenue by Type (2016-2021) & (US$ Million)
Table 97. Middle East and Africa Ibandronate Sodium Injection Revenue by Type (2022-2027) & (US$ Million)
Table 98. Middle East and Africa Ibandronate Sodium Injection Sales by Application (2016-2021) & (K Doses)
Table 99. Middle East and Africa Ibandronate Sodium Injection Sales by Application (2022-2027) & (K Doses)
Table 100. Middle East and Africa Ibandronate Sodium Injection Revenue by Application (2016-2021) & (US$ Million)
Table 101. Middle East and Africa Ibandronate Sodium Injection Revenue by Application (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Ibandronate Sodium Injection Sales by Country (2016-2021) & (K Doses)
Table 103. Middle East and Africa Ibandronate Sodium Injection Sales by Country (2022-2027) & (K Doses)
Table 104. Middle East and Africa Ibandronate Sodium Injection Revenue by Country (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Ibandronate Sodium Injection Revenue by Country (2022-2027) & (US$ Million)
Table 106. Qilu Pharmaceutical Co., Ltd Corporation Information
Table 107. Qilu Pharmaceutical Co., Ltd Description and Major Businesses
Table 108. Qilu Pharmaceutical Co., Ltd Ibandronate Sodium Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 109. Qilu Pharmaceutical Co., Ltd Ibandronate Sodium Injection Product
Table 110. Qilu Pharmaceutical Co., Ltd Recent Developments
Table 111. Hebei Renhe Yikang Pharmaceutical Co. Ltd Corporation Information
Table 112. Hebei Renhe Yikang Pharmaceutical Co. Ltd Description and Major Businesses
Table 113. Hebei Renhe Yikang Pharmaceutical Co. Ltd Ibandronate Sodium Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 114. Hebei Renhe Yikang Pharmaceutical Co. Ltd Ibandronate Sodium Injection Product
Table 115. Hebei Renhe Yikang Pharmaceutical Co. Ltd Recent Developments
Table 116. Chengdu Yuandong Biopharmaceutical Co. Ltd Corporation Information
Table 117. Chengdu Yuandong Biopharmaceutical Co. Ltd Description and Major Businesses
Table 118. Chengdu Yuandong Biopharmaceutical Co. Ltd Ibandronate Sodium Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 119. Chengdu Yuandong Biopharmaceutical Co. Ltd Ibandronate Sodium Injection Product
Table 120. Chengdu Yuandong Biopharmaceutical Co. Ltd Recent Developments
Table 121. Sichuan Meida Kang Jia Le Pharmaceutical Co. Ltd Corporation Information
Table 122. Sichuan Meida Kang Jia Le Pharmaceutical Co. Ltd Description and Major Businesses
Table 123. Sichuan Meida Kang Jia Le Pharmaceutical Co. Ltd Ibandronate Sodium Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 124. Sichuan Meida Kang Jia Le Pharmaceutical Co. Ltd Ibandronate Sodium Injection Product
Table 125. Sichuan Meida Kang Jia Le Pharmaceutical Co. Ltd Recent Developments
Table 126. Biomedical Engineering Center, Hebei Medical University Corporation Information
Table 127. Biomedical Engineering Center, Hebei Medical University Description and Major Businesses
Table 128. Biomedical Engineering Center, Hebei Medical University Ibandronate Sodium Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 129. Biomedical Engineering Center, Hebei Medical University Ibandronate Sodium Injection Product
Table 130. Biomedical Engineering Center, Hebei Medical University Recent Developments
Table 131. Roche Corporation Information
Table 132. Roche Description and Major Businesses
Table 133. Roche Ibandronate Sodium Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 134. Roche Ibandronate Sodium Injection Product
Table 135. Roche Recent Developments
Table 136. Genentech Corporation Information
Table 137. Genentech Description and Major Businesses
Table 138. Genentech Ibandronate Sodium Injection Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2016-2021)
Table 139. Genentech Ibandronate Sodium Injection Product
Table 140. Genentech Recent Developments
Table 141. Key Raw Materials Lists
Table 142. Raw Materials Key Suppliers Lists
Table 143. Ibandronate Sodium Injection Distributors List
Table 144. Ibandronate Sodium Injection Customers List
Table 145. Ibandronate Sodium Injection Market Trends
Table 146. Ibandronate Sodium Injection Market Drivers
Table 147. Ibandronate Sodium Injection Market Challenges
Table 148. Ibandronate Sodium Injection Market Restraints
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Ibandronate Sodium Injection Product Picture
Figure 2. Global Ibandronate Sodium Injection Market Share by Type in 2020 & 2027
Figure 3. 4ml:2mg Product Picture
Figure 4. 2ml:2mg Product Picture
Figure 5. 1:1mg Product Picture
Figure 6. Global Ibandronate Sodium Injection Market Share by Application in 2020 & 2027
Figure 7. Hypercalcemia
Figure 8. Osteoporosis
Figure 9. Ibandronate Sodium Injection Report Years Considered
Figure 10. Global Ibandronate Sodium Injection Sales 2016-2027 (K Doses)
Figure 11. Global Ibandronate Sodium Injection Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Ibandronate Sodium Injection Revenue 2016-2027 (US$ Million)
Figure 13. Global Ibandronate Sodium Injection Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 14. Global Ibandronate Sodium Injection Sales Market Share by Region (2016-2021)
Figure 15. Global Ibandronate Sodium Injection Sales Market Share by Region (2022-2027)
Figure 16. North America Ibandronate Sodium Injection Sales YoY (2016-2027) & (K Doses)
Figure 17. North America Ibandronate Sodium Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 18. Europe Ibandronate Sodium Injection Sales YoY (2016-2027) & (K Doses)
Figure 19. Europe Ibandronate Sodium Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Asia-Pacific Ibandronate Sodium Injection Sales YoY (2016-2027) & (K Doses)
Figure 21. Asia-Pacific Ibandronate Sodium Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Latin America Ibandronate Sodium Injection Sales YoY (2016-2027) & (K Doses)
Figure 23. Latin America Ibandronate Sodium Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Middle East & Africa Ibandronate Sodium Injection Sales YoY (2016-2027) & (K Doses)
Figure 25. Middle East & Africa Ibandronate Sodium Injection Revenue YoY (2016-2027) & (US$ Million)
Figure 26. The Top 10 and Top 5 Players Market Share by Ibandronate Sodium Injection Sales in 2020
Figure 27. The Top 10 and Top 5 Players Market Share by Ibandronate Sodium Injection Revenue in 2020
Figure 28. Ibandronate Sodium Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 29. Global Ibandronate Sodium Injection Sales Market Share by Type (2016-2027)
Figure 30. Global Ibandronate Sodium Injection Revenue Market Share by Type (2016-2027)
Figure 31. Global Ibandronate Sodium Injection Sales Market Share by Application (2016-2027)
Figure 32. Global Ibandronate Sodium Injection Revenue Market Share by Application (2016-2027)
Figure 33. North America Ibandronate Sodium Injection Sales Market Share by Type (2016-2027)
Figure 34. North America Ibandronate Sodium Injection Revenue Market Share by Type (2016-2027)
Figure 35. North America Ibandronate Sodium Injection Sales Market Share by Application (2016-2027)
Figure 36. North America Ibandronate Sodium Injection Revenue Market Share by Application (2016-2027)
Figure 37. North America Ibandronate Sodium Injection Sales Share by Country (2016-2027)
Figure 38. North America Ibandronate Sodium Injection Revenue Share by Country (2016-2027)
Figure 39. United States Ibandronate Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 40. Canada Ibandronate Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 41. Europe Ibandronate Sodium Injection Sales Market Share by Type (2016-2027)
Figure 42. Europe Ibandronate Sodium Injection Revenue Market Share by Type (2016-2027)
Figure 43. Europe Ibandronate Sodium Injection Sales Market Share by Application (2016-2027)
Figure 44. Europe Ibandronate Sodium Injection Revenue Market Share by Application (2016-2027)
Figure 45. Europe Ibandronate Sodium Injection Sales Share by Country (2016-2027)
Figure 46. Europe Ibandronate Sodium Injection Revenue Share by Country (2016-2027)
Figure 47. Germany Ibandronate Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 48. France Ibandronate Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 49. U.K. Ibandronate Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 50. Italy Ibandronate Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 51. Russia Ibandronate Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 52. Asia Pacific Ibandronate Sodium Injection Sales Market Share by Type (2016-2027)
Figure 53. Asia Pacific Ibandronate Sodium Injection Revenue Market Share by Type (2016-2027)
Figure 54. Asia Pacific Ibandronate Sodium Injection Sales Market Share by Application (2016-2027)
Figure 55. Asia Pacific Ibandronate Sodium Injection Revenue Market Share by Application (2016-2027)
Figure 56. Asia Pacific Ibandronate Sodium Injection Sales Share by Region (2016-2027)
Figure 57. Asia Pacific Ibandronate Sodium Injection Revenue Share by Region (2016-2027)
Figure 58. China Ibandronate Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 59. Japan Ibandronate Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 60. South Korea Ibandronate Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 61. India Ibandronate Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 62. Australia Ibandronate Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 63. China Taiwan Ibandronate Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 64. Indonesia Ibandronate Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 65. Thailand Ibandronate Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 66. Malaysia Ibandronate Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 67. Latin America Ibandronate Sodium Injection Sales Market Share by Type (2016-2027)
Figure 68. Latin America Ibandronate Sodium Injection Revenue Market Share by Type (2016-2027)
Figure 69. Latin America Ibandronate Sodium Injection Sales Market Share by Application (2016-2027)
Figure 70. Latin America Ibandronate Sodium Injection Revenue Market Share by Application (2016-2027)
Figure 71. Latin America Ibandronate Sodium Injection Sales Share by Country (2016-2027)
Figure 72. Latin America Ibandronate Sodium Injection Revenue Share by Country (2016-2027)
Figure 73. Mexico Ibandronate Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 74. Brazil Ibandronate Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 75. Argentina Ibandronate Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 76. Colombia Ibandronate Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 77. Middle East and Africa Ibandronate Sodium Injection Sales Market Share by Type (2016-2027)
Figure 78. Middle East and Africa Ibandronate Sodium Injection Revenue Market Share by Type (2016-2027)
Figure 79. Middle East and Africa Ibandronate Sodium Injection Sales Market Share by Application (2016-2027)
Figure 80. Middle East and Africa Ibandronate Sodium Injection Revenue Market Share by Application (2016-2027)
Figure 81. Middle East and Africa Ibandronate Sodium Injection Sales Share by Country (2016-2027)
Figure 82. Middle East and Africa Ibandronate Sodium Injection Revenue Share by Country (2016-2027)
Figure 83. Turkey Ibandronate Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 84. Saudi Arabia Ibandronate Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 85. UAE Ibandronate Sodium Injection Revenue (2016-2027) & (US$ Million)
Figure 86. Ibandronate Sodium Injection Value Chain
Figure 87. Ibandronate Sodium Injection Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

---